Research Article: Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model
Introduction:
Triple-negative breast cancer (TNBC) is characterized by an earlier onset, higher recurrence rate, and poorer prognosis compared to other breast cancer subtypes. , TNBC lacks the expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor , making targeted therapies less effective. Chemotherapy remains the primary treatment option for TNBC due to the absence of clear molecular targets and tumor heterogeneity. In recent years, immune checkpoint inhibitors (ICIs) such as…
Read more